ABSTRACT. Copy number variation (CNV) is a form of genetic variation in addition to single nucleotide polymorphisms. The significance of CNV in the manifestation of a number of diseases is only recently receiving considerable attention. We genotyped 163 dengue patients from Peninsular Malaysia for genes possibly linked to dengue infection using quantitative real-time PCR. Here, we report a serendipitous discovery of a novel rare CNV of the ABCF1 gene among the dengue patients. Among these patients, two had a gain of Rare ABCF1 CNV in dengue patients 1 copy (CN = 3) and one had lost 1 copy (CN = 1), indicating that a rare CNV of the ABCF1 gene was detected among dengue patients from Peninsular Malaysia. Although the gene is suspected to regulate inflammatory responses and pathogen-induced cytokine storm, its relevance to dengue requires further investigation.
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INTRODUCTION
Copy number variation (CNV) is an alternative form of genetic variation that, in addition to single-nucleotide polymorphisms, has recently attracted much interest in the genetic research community. CNV has been recognized for a long time at the cytogenetic level, but its impact at the genome-wide scale has not been fully appreciated until recently. CNV covers segments of DNA that contain insertions, deletions, duplications, and complex multisite variants, and it typically ranges from 0.5-1.0 kb to several megabases in size (Redon et al., 2006; Lee and Scherer, 2010) . The copy number of protein-coding genes contributes significantly to phenotypic variability and can be strikingly different between individuals, with reports of 10-fold changes in copy number of several genes (Korbel et al., 2008) , and such changes influence the mRNA and protein expression that affect gene dosage (Stranger et al., 2007) . It has been suggested that CNV is enriched in "environmentally sensitive" genes such as those involved in the immune defense system. The major histocompatibility complex/human leukocyte antigen system (MHC/HLA) is one of the most complex and variable regions in the human genome. To date, information regarding CNV in this region is relatively scarce.
The human ATP-binding cassette (ABC) transporters are one of the largest family of transporter genes, and comprise 49 members belonging to 7 subfamilies designated as A-G (Wang et al., 2011) . This gene family transports a wide range of substrate molecules across intra-and extra-cellular membranes (Dean and Allilmets, 2001 ) and serves as an important component of cellular defense mechanisms. Many of these genes have been attributed to a number of autoimmune and inflammatory diseases (Dean and Allilmets, 2001; Ota et al., 2007; Paladini et al., 2009 ); drug resistance (Saito et al., 2009) ; and a variety of diseases with complex or Mendelian genetics (Gillet et al., 2007) . The ATP-binding cassette subfamily F member 1 (ABCF1) gene is a member of the GCN20 subfamily, located at 6p21.33 adjacent to HLA-E in the MHC region (Paladini et al., 2009) , with a size of ~21 kb ( Figure 1 ). This gene is not well studied, and, hence, knowledge on its functional role is relatively limited (Dean and Allilmets 2001; Ota et al., 2007; Wang et al., 2011) . However, it is believed that the ABCF1 protein may be regulated by tumor necrosis factor-alpha and may play a role in the enhancement of protein synthesis and the inflammation process; thus, ABCF1 may have a role in several autoimmune diseases (Richard et al., 1998; Wang et al., 2011) .
In an attempt to identify potential genes that predispose individuals to severe dengue infection, we serendipitously identified a novel rare CNV of the ABCF1 gene. To date this CNV has not been previously reported elsewhere such as in the Database of Genomic Variants (DGV; http://projects.tcag.ca/variation/).
MATERIAL AND METHODS
In total, 163 hospitalized patients with laboratory-confirmed dengue infection (either dengue fever or dengue hemorrhagic fever) were enrolled in this study. These subjects were recruited from the Hospital Universiti Sains Malaysia (HUSM), Hospital Kota Bharu, and Universiti Malaya Medical Centre (UMMC) as study participants to investigate genetic susceptibility to dengue infection. The study was approved by the respective Research and Ethics Committee, i.e., University Malaya (UM) (reference No. 607.8), Universiti Sains Malaysia (USM) [USMKK/PPP/JePeM [211.3.(6)], and Ministry of Health (NMRR-09-1128-4211). All subjects provided informed and written consent to the genetic study. Three milliliters of peripheral blood was withdrawn from the recruited subjects and genomic DNA was extracted from either whole or clotted blood.
The copy number of the ABCF1 gene in each patient was determined using relative quantitative real-time polymerase chain reaction (qRT-PCR). Amplification of the ABCF1 gene and a reference gene, encoding telomerase reverse transcriptase (TERT), was performed simultaneously using a pre-designed TaqMan copy number assay (targeting a DNA region close to the central region of the gene, chr6:30656260; Figure 2 ) and TaqMan copy number reference assay (Applied Biosystems), respectively. The qRT-PCR mix, containing 4 µL of each DNA sample (5 ng/µL), was prepared according to the manufacturer protocol and was run using the default thermal cycling conditions. All samples were measured in triplicates. The amplification efficiencies for the ABCF1 and TERT genes were assessed by constructing a standard curve with a serial dilution of a reference DNA sample. After PCR amplification, data files containing the sample replicate C T values for each reporter dye were exported into the ABI Copy Number Caller software (Applied Biosystems) to determine the gene copy number in each sample. The software provides the statistical analysis by calculating the confidence values for each copy number call using the maximum likelihood algorithm. Samples were excluded from further analysis if they failed to give PCR products after 3 amplification attempts. 
RESULTS AND DISCUSSION
Of the 163 subjects genotyped, two were identified to have gained 1 copy of the ABCF1 gene (CN = 3), whereas loss of 1 copy was detected in one subject (Table 1 ). Figure 3 shows the unrounded copy number calls and estimated CNV in the ABCF1 gene. Although CNVs in the regions of the MHC class II and class III genes have been recognized (Traherne, 2008) , the CNV status in the class I region, where the HLA-E and ABCF1 genes are located, remains to be identified. To date, no description of CNV in the ABCF1 exists in the Database of Genomic Variants (DGV; http://projects.tcag.ca/variation/); therefore, the discovery of a CNV in the ABCF1 gene among the dengue patient cohort was unexpected. ABCF1 has previously been identified as an important gene in the regulation of inflammatory responses (Ota et al., 2007; Paladini et al., 2009 ) especially in pathogen-induced cytokine storm (Wilcox, 2010) . These events are prominent features of severe dengue infection, but the relevance of the ABCF1 CNV to the outcome of severe dengue infection cannot be ascertained until a larger number of samples are analyzed.
In summary, we observed a novel rare CNV in the ABCF1 gene in 3 subjects with dengue infection in Peninsular Malaysia. CNV in the ABCF1 gene has not been previously reported. However, its relevance to dengue infection cannot be ascertained because of inadequate sample size. A. Unrounded copy number; B. predicted copy number by ABI Copy Number Caller. Samples highlighted in red failed in the PCR assays and were repeated for three attempts to confirm the presence of copy number calls (data not shown). We suspected that the failure of these samples was due to bad quality of DNA samples instead of CN = 0.
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